MAGON LORD: Open Payments
NPI 1710550843 · AUGUSTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 56 payments from 15 companies in 2025. Trend: 2023 $634 · 2024 $1,287 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $289 |
| Janssen Biotech, Inc. | 3 | $273 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $267 |
| Ipsen Biopharmaceuticals, Inc | 2 | $143 |
| Phathom Pharmaceuticals, Inc. | 1 | $109 |
| PFIZER INC. | 3 | $48 |
| GENZYME CORPORATION | 1 | $31 |
| Mallinckrodt Hospital Products Inc. | 1 | $27 |
| Madrigal Pharmaceuticals | 1 | $24 |
| QOL Medical, LLC | 1 | $23 |
Products named: TREMFYA, XIFAXAN, IQIRVO, VOQUEZNA, LINZESS, RINVOQ, SKYRIZI, DUPIXENT.
Industry payments across GA — which companies pay providers there.
